Similarly, cytosolic nucleic acid sensors, including DHX58 which is regulated by IRF1 [38], could stimulate type I IFN production and may serve as potential therapeutic targets for SLE [39, 40]. This evidence concerns the gene IRF1 and systemic lupus erythematosus.